Polyribosomes, carrying nascent polypeptide chains, were prepared from whole brain, cortex, and hindbrain-medullary white matter of young adult rats. In a homologous cell-free system, a brain-specific protein (S100 protein) was identified in the mixture of polypeptides released from the polyribosomes during incubation for 1 hr at 37°. De novo synthesis of the S100 protein was achieved in a reconstituted cerebral cell-free system containing polysome-derived mRNA and 40S + 60S subunits. The radioactively labeled S100 protein synthesized in vitro was identified by precipitation with antibody to S100 after addition of purified S100 as a carrier, and migration of the solubilized precipitate on acrylamide gels in the presence of sodium dodecyl sulfate. In vitro synthesis of the S100 protein did not occur in analogous cell-free systems derived from hepatic tissue or in a heterologous system containing liver polyribosomes and cerebral enzymes.
One of the active areas of research on mammalian protein biosynthesis has been the identification of products formed during cell-free incorporation of amino acids by polyribosomal preparations. The demonstration of active incorporation into globin chains by particles from reticulocytes was the first example of clear-cut evidence for an identifiable product formed in vitro (1) (2) (3) . Some of the more recent and numerous examples include the demonstration of active incorporation into serum proteins and nonserum liver proteins by particulate preparations from hepatic tissue (4) (5) (6) (7) (8) (9) (10) (11) , into myosin by polyribosomes from embryonic-chick muscle (12) and myoglobin by polysomes from duck skeletal muscle (13) , into heavy and light chains of antibodies by polysomes from rabbit lymph nodes (14, 15) and ovalbumin by chick-oviduct polysomes (16) , and into B-lactoglobulin by particles from ewe mammary gland (17) .
Although cell-free systems dervied from brain are highly active in amino-acid incorporation (18) (19) (20) (21) , identification of products formed in vitro is difficult because of the complexity and heterogeneity of cerebral tissue. Nevertheless, Rubin and Stenzel (22) reported the in vitro synthesis of a soluble acidic protein (S100 protein) by a ribosomal system from rabbit cortical gray matter. Mahler and Brown (21) later reported that in a polysomal system from rat brain, about 33% of the counts released into the soluble portion during cell-free protein synthesis were found among several acidic proteins, but identification of a specific protein was not attempted in their studies. The isolation, purification, and characterization of two brain-specific low molecular weight proteins by Moore et al., as well as preparation of antisera to these proteins, has made possible a study of the in vitro synthesis of specific brain proteins by cerebral polyribosomes. The S100 protein (23) is primarily of glial origin (24) (25) (26) , and represents 0.2% of the total soluble protein of brain. The other purified protein (14-3-2) is localized primarily in neurons (27) . The function of these proteins is unknown, but the S100 protein has been implicated in neurophysiological functions (28, 29) and behavioral parameters (30) .
This report describes a cerebral polyribosomal system that directs the in vitro synthesis of S100 protein. Furthermore, a reconstituted system has been developed consisting of purified 40S and 60S subunits from rat brain, and cerebral polysome-derived mRNA, which, in the presence of appropriate energy sources, factors, and enzymes, directs the de novo synthesis of this specific S100 protein$. The directed synthesis of a specific protein by isolated mRNA has been shown in several mammalian cell-free systems (31) (32) (33) (34) (35) (36) (37) . How 105,000 X g and 00. The upper two-thirds of the postmicrosomal supernatant was divided into 1-ml aliquots and stored in liquid nitrogen. The microsomal pellets were rinsed with the sucrose-Tris buffer and used for preparation of ribosomal wash factors.
The pH 5 fractions were obtained from postmicrosomal supernatants of cerebral homogenates (whole brain, cortex, and white matter) by precipitation with 1 N acetic acid at pH 4.7 (40) . The addition of 1 mM dithiothreitol to the isolation media, as well as the suspension medium for storage of the pH 5 fractions, increased the activity for cell-free protein synthesis (41) (42) (43) .
Ribosomal factors, for use in reconstituted cell-free systems, were prepared from microsomes or free polysomes isolated from rat cerebral cortex. These particulate fractions were treated with high salt (0.6 M KCl) to obtain ribosomal wash factors (44, 45) .
Preparation of Hepatic Polyribosomes, S-l05, and pH 5 Fractions. These subcellular components were prepared from hepatic tissue of rats fasted 16-18 hr to deplete liver glycogen. The procedure of Falvey and Staehelin was used for preparation of total polyribosomes from deoxycholate-treated post-. mitochondrial supernatant (46) . However, KCl was substituted for the NH4Cl used in the original method.
The S-105 fraction was also prepared by the method of Falvey and Staehelin, with the use of KCl in the isolation media. The pH 5 fraction, on the other hand, was more active for in vitro polypeptide synthesis when prepared as described above for cerebral tissue, except that a pH of 5.1 rather than 4.7 was used. Isolation of Polysome-Derived mRNA. RNA, released by EDTA treatment of total polyribosomes from cerebral white matter and whole brain of rats, was prepared as described by Zomzely, Roberts, and Peache (47) . This polysome-derived RNA was shown, by indirect criteria, to have properties expected of mRNA.
Preparation of Subunits from Rat Brain. Total polysomes isolated from whole brain of rats were used as the source of subunits. The polysomes were incubated in a protein-synthesizing system for 30 min; puromycin (pH 7.0) was added, and incubation was continued for an additional 20 min. The monoribosomes formed by this treatment were dissociated to 40S and 608 subunits by exposure to high concentrations of potassium in the presence of dithiothreitol (manuscript in preparation). The subunits were separated by sucrose density gradient fractionation, identified by passage through an ISCO (Instrument Specialties Co., Lincoln, Nebr.) gradient analyzer, collected, and pelleted by centrifugation at 105,000 X g for 16 hr at 40 or concentrated by ethanol precipitation (48) . with agitation. The samples were then transferred to an ice bath, and aliquots were taken for determination of total radioactivity (38) . After centrifugation of the incubated samples for 3 hr at 40,000 rpm and 00 to pellet the ribosomes, the supernatant fractions were carefully removed, the volume was measured, and aliquots were taken for determination of radioactivity released during incubation. The soluble fractions from 2-3 incubations were pooled to obtain a sufficiently high level of radioactivity for identification of proteins synthesized in vitro. The pooled samples were dialyzed against 0.01 M sodium phosphate (pH 7.4)-0.15% NaCl-0.05 M 2-mercaptoethanol-0.1% unlabeled amino-acid mixture.
Measurement of Polypeptide Synthesis and Release by a Reconstituted Cerebral Cell-free System. Purified 60S and 40S subunits suspended in 50 mM Tris -HCl (pH 7.6)-5 mM MgCl2-100 mM KCl-1 mM dithiothreitol were used in the reaction mixture, at a concentration of 8 A20 and 4 A20 units, respectively. Polysome-derived mRNA was added at 200 Mg/mi1, ribosomal wash factors at 100 ,ug of protein per ml, and tRNA at 0.2 mg/ml. Other components of the incubation system were present in the same concentrations as described for the polysomal cell-free system. The reaction mixture was incubated at 370 for 60 min; isolation and dialysis of the soluble fraction was done as described for the incubation system containing polysomes.
Sucrose Density Gradient Analyses. Sedimentation analyses were done in linear sucrose gradients (15-35%) at 0-4°. The polysomes, incubated in the protein-synthesizing system, were analyzed for sucrose gradient profile, as well as for hot MCr-COOH-insoluble radioactivity of 1-ml fractions collected from the gradient (38) . The sucrose gradients contained 50 mM Tris -HCl (pH 7.6)-5 mM MgCI2-100 mM KCl. Purified 40S and 60S subunits were also analyzed by the sucrose density technique with either the low-salt gradient (see above) or a high-salt gradient containing 50 mM Tris -HCl (pH 7.6)-i mM MgCl2-300 mM KCl. Ultraviolet absorbances of the fractions were monitored continuously at 254 nm with an ISCO model UA-2 ultraviolet analyzer and an external recorder.
Assay of the Brain-Specific Protein (Si00 Protein). The dialyzed soluble protein fractions obtained from incubation of cerebral polysomes and the reconstituted mRNA-subunit system were treated as described by Herschman (49) for immuno-Nadod S04 gel isolation of labeled S100 protein. The samples were heated for 10 min at 700, and the major fraction of soluble proteins was removed by centrifugation at 27,000 X g for 15 min. After concentration by Sephadex G-200 and subsequent dialysis against 0.01 M sodium phosphate (pH 7.4)-0.15% NaCI, purified carrier S100 protein (25 Mg) and 0.12 ml of antiserum were added to each sample. The purified S100 protein was prepared from beef brain (50) ; antiserum to the bovine S100 protein was prepared as described (51) . After incubation for 1 hr at 370 and 24 hr at 40, the resulting precipitates were washed three times with cold 0.01 M sodium phosphate (pH 7.4)-0.15% NaCl solution and were dissolved in 0.1 ml of Nadod S04 dissolving buffer. 50-,u Aliquots of the dissolved precipitates were subjected to electrophoresis on Nadod-SO4 acrylamide gels, as described by Weber and Osborn (52) . Gels were stained with 0.05% Coomassie After the samples were cooled to room temperature, 20 sl of a 4% aqueous solution of ascorbic acid was added to each sample, followed by addition of 10 ml of a scintillation mixture (38 (53) .
Protein was determined by the method of Lowry et al. (54), with bovine-serum albumin as standard (55) .
RESULTS
In vitro synthesis of brain-specific S100 protein by a cerebral polysomal cell-free system Previous efforts by other investigators (21, 22) , as well as by us (38, 40) , have resulted in polysomal cell-free systems from brain with high efficiency in protein synthesis. However, extensive conversion of polysomes into 80$ ribosomes, with concomitant release of the nascent polypeptide chains, has been obtained to only a limited extent. Completion and release of the labeled nascent polypeptides from the polysomes did not exceed 40% of the total incorporated amino acids. Since the mRNAs of isolated cerebral polysomes would be expected to direct the synthesis of a large variety of proteins, identification of a single protein, such as the S100 protein, would be facilitated by a higher level of release of nascent chains from the polysomes during incubation of the cell-free system. Accordingly, various conditions were investigated, not only for preparation of components of the cell-free system, but also for incubation. The modifications described in Methods yielded the results shown in Fig. 1 . After 60 min of incubation of the cerebral polysomal cell-free system, 80-85% of the labeled nascent polypeptides had been released from the polysomes, with conversion of the major-fraction of the polysomes to 80$ ribosomes.
In the assay for identification of labeled S100 protein synthesized in vitro by cerebral polysomes, we used the technique described by Herschman (49) , which combines immunocoprecipitation of the labeled S100 with antibody to S100 in the presence of pure carrier S100 with Nadod S04-acrylamide gel electrophoresis of the dissolved antigenantibody precipitate. We have found this procedure to be a specific and quantitative assay for incorporation of radioactive amino acids into S100 protein, in agreement with the results obtained by Herschman in studies with cloned cultured human glial cells. In the report of Rubin and Stenzel (22) on the in vitro synthesis of S100 by rat brain extracts, only 10% release of labeled nascent polypeptide chains was obtained during cell-free amino-acid incorporation; immunocoprecipitation was performed on the soluble portion without preliminary purification. Their results showed that as much as 10-15% of the soluble protein synthesized in their system was S100 protein. However, we have found that their method leads to appreciable nonspecific absorption or trapping of radioactive material, a result similar to those of other investigators (49, 55) . A summary of the data obtained with our procedure is shown in Table 1 . The proportion of labeled S100 protein synthesized in vitro by these cerebral polysomal cell-free systems ranges from 0.12 to 0.52% of amino acids incorporated into total soluble protein. These results are in a range comparable to those obtained by Herschman (49) for cloned cultures of glial cells (0.06%). Although our values are higher, it is difficult to make exact comparisons between results obtained with gliomas and cerebral systems obtained from animals, particularly since in our experiments an isolated polysomal cell-free system was used. The hepatic systems are used as controls, because $100 is a brain-specific protein (23) that should not be synthesized by the noncerebral system. Although some radioactivity appears in the region of the S100 protein after immunocoprecipitation and Nadod S04-acrylamide gel electrophoresis of the products of hepatic polysomal cell-free synthesis (Table 1) , this finding represents nonspecific contamination. In Fig. 2 , it is apparent that the radioactivity in the $100 region of the hepatic control gel does not exhibit any peak of counts, and is in the range of the background activity throughout the gel for both cerebral and hepatic systems. The in vitro synthesis of S100 protein is also clearly dependent on cerebral polysomal mRNA, since substitution of liver for brain polysomes did not lead to formation of the S100 protein (Fig. 2, Table 1 ). Furthermore, since S100 protein has been shown to be primarily of glial origin (24) (25) (26) , gross brain fractions were assayed that contained different proportions of glial cells. The polysomal system obtained from hindbrain-medullary white matter, with the highest proportion of glial cells (56) , showed the greatest in vitro synthesis of the S100 protein. Since total polysomes, which consist of free and membrane-bound particles, were used in the cell-free system, the class of polysomes involved in the synthesis of S100 protein cannot be determined from these experiments.
De novo synthesis of brain-specific S100 protein by a reconstituted cerebral cell-free system from rat brain
An RNA fraction containing mRNA-like material (DNA-like base composition, high level of DNA-RNA hybridization, stimulation of amino-acid incorporation in vitro), prepared from cerebral polysomes (47) , was used in experiments designed to investigate de novo synthesis of specific proteins by this cerebral cell-free system. S100 protein was used as the marker for evidence of in vitro synthesis of a specific protein programmed by an isolated mRNA fraction. In the search for optimal conditions for efficient protein synthesis in vitro, we found it necessary to prepare purified 40S and 60S subunits (Fig. 3) . Since the studies with cerebral polysomal systems had shown that a much higher level of in vitro synthesis of S100 occurred when the polysomes were prepared from whole brain and cerebral white matter (Table 1) , mRNAs were isolated from polysomes derived from these sources. Incubation of polysome-derived mRNA, 40S and 60S subunits, as well as other components of the cell-free system, resulted in the synthesis of S100 protein (Fig. 4) (12, 14) , should prove fruitful with the cerebral polysomal cell-free system. Another area of investigation that may be facilitated by the use of functional cerebral mRNAs and active ribosomal subunits is that of the mechanism of initiation and termination in mammalian protein-synthesizing systems from morphologically complex tissues, such as brain.
Since one of the aims of our investigations on cerebral protein synthesis is a study of environmental and behavioral effects on this process, a search for correlations between the synthesis of specific proteins and activity of the nervous system may provide valuable information. The cerebral polysomal cell-free system described in this report, and-perhaps even more important, the reconstituted system, can be used to investigate the effect of various environmental factors on the synthesis of brain-specific proteins that may be involved in memory and learning.
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